Efficacy and safety of anlotinib plus anti-PD-1 agents in patients with refractory advanced biliary tract cancers
Article in Clinical and Translational Oncology (March 2024)
The most recent citing publications are shown below. View all 74 publications that cite this research output on Dimensions.
Article in Clinical and Translational Oncology (March 2024)
Preprint in Research Square (February 2024)
Article in Journal of Leukocyte Biology (February 2024)